Connor, Clark & Lunn Investment Management Ltd. Aclaris Therapeutics, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$26 Billion
Q2 2025

A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 797,134 shares of ACRS stock, worth $1.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

797,134

Previous 865,011 7.85%

Holding current value

$1.6 Million

Previous $1.32 Million 14.51%

% of portfolio

0.0%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 07, 2025	SELL	$1.08 - $1.63 $73,307 - $110,639	-67,877 Reduced 7.85%	797,134 $1.13 Million
Q1 2025 May 12, 2025	SELL	$1.53 - $2.6 $67,026 - $113,900	-43,808 Reduced 4.82%	865,011 $1.32 Million
Q4 2024 Feb 10, 2025	BUY	$1.15 - $4.59 $662,874 - $2.65 Million	576,413 Added 173.41%	908,819 $2.25 Million
Q3 2024 Nov 08, 2024	BUY	$1.12 - $1.4 $242,845 - $303,556	216,826 Added 187.6%	332,406 $375,000
Q2 2024 Aug 09, 2024	BUY	$1.01 - $1.36 $14,955 - $20,137	14,807 Added 14.69%	115,580 $127,000
Q1 2024 May 09, 2024	BUY	$0.92 - $1.44 $92,711 - $145,113	100,773 New	100,773 $124,000
Q3 2023 Nov 13, 2023	SELL	$6.56 - $10.95 $63,002 - $105,163	-9,604 Reduced 4.56%	201,233 $1.38 Million
Q2 2023 Aug 10, 2023	BUY	$7.89 - $10.64 $269,735 - $363,749	34,187 Added 19.35%	210,837 $2.19 Million
Q1 2023 May 09, 2023	BUY	$7.07 - $17.95 $1.13 Million - $2.87 Million	159,804 Added 948.62%	176,650 $1.43 Million
Q4 2022 Feb 10, 2023	SELL	$14.33 - $18.37 $143,414 - $183,846	-10,008 Reduced 37.27%	16,846 $265,000
Q3 2022 Nov 10, 2022	BUY	$13.07 - $18.22 $350,981 - $489,279	26,854 New	26,854 $423,000
Q4 2020 Feb 16, 2021	SELL	$2.65 - $7.61 $83,673 - $240,285	-31,575 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$1.5 - $2.71 $47,362 - $85,568	31,575 New	31,575 $81,000

Others Institutions Holding ACRS

# of Institutions

Shares Held

87.6M

Call Options Held

Put Options Held

View Full List

About Aclaris Therapeutics, Inc.

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $134M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

More about ACRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account

Connor, Clark & Lunn Investment Management Ltd. Aclaris Therapeutics, Inc. Transaction History